129 related articles for article (PubMed ID: 38206204)
1. HBV infection effects prognosis and activates the immune response in intrahepatic cholangiocarcinoma.
Li Z; Gao Q; Wu Y; Ma X; Wu F; Luan S; Chen S; Shao S; Shen Y; Zhang D; Feng F; Yuan L; Wei S
Hepatol Commun; 2024 Jan; 8(1):. PubMed ID: 38206204
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus-related intrahepatic cholangiocarcinoma originates from hepatocytes.
Song Z; Lin S; Wu X; Ren X; Wu Y; Wen H; Qian B; Lin H; Huang Y; Zhao C; Wang N; Huang Y; Peng B; Li X; Peng H; Shen S
Hepatol Int; 2023 Oct; 17(5):1300-1317. PubMed ID: 37368186
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus infection: a favorable prognostic factor for intrahepatic cholangiocarcinoma after resection.
Zhou HB; Wang H; Li YQ; Li SX; Wang H; Zhou DX; Tu QQ; Wang Q; Zou SS; Wu MC; Hu HP
World J Gastroenterol; 2011 Mar; 17(10):1292-303. PubMed ID: 21455328
[TBL] [Abstract][Full Text] [Related]
4. Impact of hepatitis B virus infection on outcome following resection for intrahepatic cholangiocarcinoma.
Zhang L; Cai JQ; Zhao JJ; Bi XY; Tan XG; Yan T; Li C; Zhao P
J Surg Oncol; 2010 Mar; 101(3):233-8. PubMed ID: 20169539
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of hepatitis B virus infection in patients with intrahepatic cholangiocarcinoma.
Ahn CS; Hwang S; Lee YJ; Kim KH; Moon DB; Ha TY; Song GW; Lee SG
ANZ J Surg; 2018 Mar; 88(3):212-217. PubMed ID: 27598539
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus is associated with the clinical features and survival rate of patients with intrahepatic cholangiocarcinoma.
Tao LY; He XD; Xiu DR
Clin Res Hepatol Gastroenterol; 2016 Dec; 40(6):682-687. PubMed ID: 27282820
[TBL] [Abstract][Full Text] [Related]
7. Isolated anti-HBc is an independent risk factor for tumor recurrence in intrahepatic cholangiocarcinoma after curative resection.
Xu XB; Hu C; Yang HJ; Zheng SS
Hepatobiliary Pancreat Dis Int; 2022 Oct; 21(5):472-478. PubMed ID: 35948505
[TBL] [Abstract][Full Text] [Related]
8. Implications of Intrahepatic Cholangiocarcinoma Etiology on Recurrence and Prognosis after Curative-Intent Resection: a Multi-Institutional Study.
Zhang XF; Chakedis J; Bagante F; Beal EW; Lv Y; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Groot Koerkamp B; Guglielmi A; Itaru E; Pawlik TM
World J Surg; 2018 Mar; 42(3):849-857. PubMed ID: 28879598
[TBL] [Abstract][Full Text] [Related]
9. Occult hepatitis B virus infection in Chinese cryptogenic intrahepatic cholangiocarcinoma patient population.
Li Y; Wang H; Li D; Hu J; Wang H; Zhou D; Li Q; Jiang X; Zhou H; Hu H
J Clin Gastroenterol; 2014; 48(10):878-82. PubMed ID: 24356457
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus-associated intrahepatic cholangiocarcinoma: a malignancy of distinctive characteristics between hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Jeong S; Tong Y; Sha M; Gu J; Xia Q
Oncotarget; 2017 Mar; 8(10):17292-17300. PubMed ID: 28030846
[TBL] [Abstract][Full Text] [Related]
11. Prognosis of Intrahepatic Cholangiocarcinomas with HBV Infection is Better than Those with Hepatolithiasis After R0 Liver Resection: A Propensity Score Matching Analysis.
Wang Q; Li J; Lei Z; Wu D; Si A; Wang K; Wang Y; Wan X; Lau WY; Shen F
Ann Surg Oncol; 2017 Jun; 24(6):1579-1587. PubMed ID: 28058554
[TBL] [Abstract][Full Text] [Related]
12. Prognosis after resection for hepatitis B virus-associated intrahepatic cholangiocarcinoma.
Wu ZF; Wu XY; Zhu N; Xu Z; Li WS; Zhang HB; Yang N; Yao XQ; Liu FK; Yang GS
World J Gastroenterol; 2015 Jan; 21(3):935-43. PubMed ID: 25624728
[TBL] [Abstract][Full Text] [Related]
13. Antiviral therapy improves survival in patients with HBV infection and intrahepatic cholangiocarcinoma undergoing liver resection.
Lei Z; Xia Y; Si A; Wang K; Li J; Yan Z; Yang T; Wu D; Wan X; Zhou W; Liu J; Wang H; Cong W; Wu M; Pawlik TM; Lau WY; Shen F
J Hepatol; 2018 Apr; 68(4):655-662. PubMed ID: 29155069
[TBL] [Abstract][Full Text] [Related]
14. Postoperative Prognosis of Non-alcoholic Fatty Liver Disease-Associated Intrahepatic Cholangiocarcinoma: a Multi-center Propensity Score Matching Analysis.
Yu Q; Lei Z; Ma W; Yang F; Tang H; Xiao Q; Tang X; Si A; Yang P; Zhou N; Cheng Z
J Gastrointest Surg; 2023 Nov; 27(11):2403-2413. PubMed ID: 37582919
[TBL] [Abstract][Full Text] [Related]
15. Analysis of viral integration reveals new insights of oncogenic mechanism in HBV-infected intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma.
Zhao L; Wang Y; Tian T; Rao X; Dong W; Zhang J; Yang Y; Tao Q; Peng F; Shen C; Wang S; Liu H; Zeng X; Zhou W
Hepatol Int; 2022 Dec; 16(6):1339-1352. PubMed ID: 36123506
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of hepatitis B or C on intrahepatic cholangiocarcinoma.
Seo JW; Kwan BS; Cheon YK; Lee TY; Shim CS; Kwon SY; Choe WH; Yoo BC; Yoon JM; Lee JH
Korean J Intern Med; 2020 May; 35(3):566-573. PubMed ID: 31916422
[TBL] [Abstract][Full Text] [Related]
17. Recurrence and prognosis in intrahepatic cholangiocarcinoma patients with different etiology after radical resection: a multi-institutional study.
Li Q; Chen C; Su J; Qiu Y; Wu H; Song T; Mao X; He Y; Cheng Z; Li J; Zhai W; Zhang D; Geng Z; Tang Z
BMC Cancer; 2022 Mar; 22(1):329. PubMed ID: 35346122
[TBL] [Abstract][Full Text] [Related]
18. Distinct PD-L1/PD1 Profiles and Clinical Implications in Intrahepatic Cholangiocarcinoma Patients with Different Risk Factors.
Lu JC; Zeng HY; Sun QM; Meng QN; Huang XY; Zhang PF; Yang X; Peng R; Gao C; Wei CY; Shen YH; Cai JB; Dong RZ; Shi YH; Sun HC; Shi YG; Zhou J; Fan J; Ke AW; Yang LX; Shi GM
Theranostics; 2019; 9(16):4678-4687. PubMed ID: 31367249
[No Abstract] [Full Text] [Related]
19. [Prognostic value of preoperative peripheral blood neutrophil-to-lymphocyte ratio and γ-glutamyl transpeptidase-to-platelet ratio index in patients with hepatitis B virus related intrahepatic cholangiocarcinoma after radical resection].
Li Q; Zhang R; Fu JL; Zhang J; Su JB; Jin ZC; Chen C; Zhang D; Geng ZM
Zhonghua Yi Xue Za Zhi; 2021 Oct; 101(38):3134-3140. PubMed ID: 34674423
[No Abstract] [Full Text] [Related]
20. Clinicopathological Features and Post-resection Prognosis of Double Primary Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
Jung DH; Hwang S; Kim KH; Hong SM; Lee YJ; Ahn CS; Moon DB; Ha TY; Song GW; Park GC; Yu ES; Lee SG
World J Surg; 2017 Mar; 41(3):825-834. PubMed ID: 27812807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]